Netherlands news - the latest biotech news from Labiotech.eu

Home Netherlands Page 7

Latest Posts

Bulletproof skin Jalila Essaidi

News and Trends 30 Jul 2018

This Bulletproof Skin is Made of Goat Milk Spider Silk

Jalila Essaïdi is a Dutch artist and entrepreneur focused on biotech applications of spider silk, which she makes using the milk of genetically engineered goats. Spider silk is one of the strongest materials in nature. Jalila Essaïdi had her curiosity piqued when she read about the work of Randolph Lewis, a Professor at Utah State […]

July 30, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

keytruda cover

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer patients. The inventors told us their story, from the drug’s early days to their current role as executives of the biotech unicorn Aduro. Since 2014, the cancer drug Keytruda, also known as pembrolizumab, continues to be widely sought after due […]

July 24, 2018 - 6 minutesmins - By Editorial Team

CAR T Gamma Delta T cells

News and Trends 19 Jul 2018

Kite Partners with Dutch Biotech to Develop a New Form of CAR-T Therapy

Kite will support Gadeta in the development of a new type of CAR-T therapy that could be more effective in solid tumors. Approved just last year, CAR-T cell therapy is offering hope to patients with severe forms of blood cancer. The developer of one of only two CAR-T therapies currently in the market, Kite, has […]

July 19, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Lab grown meat Mosa Meat

More News! 18 Jul 2018

Lab-Grown Meat Will Be on the Market in 2021

Dutch startup Mosa Meat has raised €7.5M in a Series A round, which will support the development of a first lab-grown meat product that is expected to make it to market by 2021. Mosa Meat is a Dutch startup co-founded by Mark Post, the scientist behind the world’s first lab-grown burger. After an early investment […]

July 18, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Blood Clotting Cover

News and Trends 2 Jul 2018

Dutch Snake Venom-Derived Clotting Agent Comes Closer to the Clinic

Dutch biotech raises €12.5M to complete the preclinical development of its lead compound for acute internal bleeding and bring the drug into clinical trials. VarmX, based in Leiden, the Netherlands, raised a Series A round of €7.5M led by BioGeneration Ventures, with an additional €5M provided by the Netherlands Enterprise Agency as an Innovation Credit. The […]

July 2, 2018 - 1 minutemin - By Alexander Burik

VarmX BOTW Cover Image

Startup Scout 1 Jun 2018

This Dutch Biotech Gets Inspiration From Snake Venom to Restore Blood Clotting

This week we’re in Leiden, the Netherlands, visiting VarmX. The biotech develops therapeutic proteins based on a peptide found in snake venom to restore blood clotting in patients with acute bleeding. Mission: Founded in 2016 as a spin-out from the University of Leiden, VarmX aims to restore blood clotting in patients with acute, internal bleeding after taking […]

June 1, 2018 - 2 minutesmins - By Alexander Burik

ADVERTISEMENT

Xenikos Graft Versus Host Disease

News and Trends 15 May 2018

Series B Funding Helps Dutch Biotech Fight Graft Versus Host Disease

Xenikos has raised $30M (€25M) in Series B funding to conduct Phase III trials for its treatment for acute graft-versus-host disease, a complication of stem cell transplants. Xenikos has raised a substantial Series B fundraising round to conduct Phase III trials in the US and the EU for T-Guard, its treatment for steroid-resistant acute graft […]

May 15, 2018 - 2 minutesmins - By Alexander Burik

uniQure Gene Therapy Public Offering

News and Trends 3 May 2018

World’s First Gene Therapy Developer Raises $128M for Hemophilia and Huntington’s

uniQure has raised a substantial public offering on the NASDAQ. The funding could help the Dutch biotech advance two new gene therapies after the withdrawal of its first treatment. Amsterdam-based uniQure has raised an ambitious $128M (€107M) in a public offering at the beginning of next week. The Dutch biotech develops gene therapies for hemophilia and Huntington’s disease, for […]

May 3, 2018 - 2 minutesmins - By Alexander Burik

Forbion Lung Disease Small Cover Image

News and Trends 12 Apr 2018

British Biotech Raises £29M Round to Fight Lung Disease

Enterprise Therapeutics has raised a substantial Series B financing round to bring its treatments for respiratory diseases into clinical development. Enterprise Therapeutics, a British biotech, has raised £29M (€33M) in Series B from several investors including Forbion, one of the most active European life science VCs. In Enterprise, Forbion has found a replacement in its portfolio for the Dutch […]

April 12, 2018 - 2 minutesmins - By Alexander Burik

Organ on a Chip Mimetas

News and Trends 11 Apr 2018

Dutch Organs-on-Chips Raises $20.5M in Series B Financing

MIMETAS, a Dutch biotech, has raised a Series B financing round to continue developing its organ-on-a-chip platform, which could remove the need to use animals in preclinical drug testing. MIMETAS, based in Leiden, has secured $20.5M (€17M) in Series B financing from investors in Asia and Europe. The company will use the funding to develop its organ-on-a-chip […]

April 11, 2018 - 2 minutesmins - By Alexander Burik

Research News Hospital Waste Management

News and Trends 10 Apr 2018

Microbes Come to the Rescue to Reduce Hospital Waste

Hospital waste management is no laughing matter, given that one hospital bed can produce up to 0.5 kg of waste per day. A Dutch technology is using microbes to optimize the process with anaerobic digestion. We look to hospitals and our healthcare systems at large for treatment and reassurance when we are sick, but it […]

April 10, 2018 - 2 minutesmins - By Alexander Burik

Polyganics Surgical Sealant Patch

News and Trends 12 Mar 2018

FDA Says Dutch Surgical Sealant Patch Could Save Lives

Polyganics has received a Breakthrough Device Designation from the FDA for its biodegradable sealant patch for surgical wounds. Polyganics, based in Groningen, the Netherlands, specializes in medical devices that use natural polymers to help regenerate injured tissue. The FDA granted a Breakthrough Device Designation for its Liver and Pancreas Sealant Patch. The patch uses Polyganics polymer technology to seal […]

March 12, 2018 - 2 minutesmins - By Alexander Burik

ADVERTISEMENT